Global Endoscopy Equipment Market Outlook and Growth Prospects: APEJ forecasted to Emerge as Fastest-Growing Market during 2017 – 2022

Market Research HUB Market Research HUB

Albany, US, 2017-Nov-14 — /EPR Network/ —  Endoscopy has become a popular tool for diagnosis as well as for minimally invasive surgical procedures. With the increasing incidences of gastrointestinal diseases and cancers of the stomach and digestive tract, endoscopy is the most widely used procedure and the driver to the endoscopy device and equipment market. According to the latest findings, the rapid growth of the healthcare sector in developing economies in Asia Pacific except Japan (APEJ) is likely to be a major driver for the global endoscopy equipment market in the future years. Considering the rapid growth in the market, a new research study titled “Endoscopy Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022” has been prepared and now broadcasted to the massive repository of Market Research Hub (MRH). The research study is titled as “Endoscopy Equipment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022” which provides a clear look at the various components of the market to provide a detailed overview of current scenario as well as future prospects till 2022.

Request Free Sample Report@

As per the research outcomes, the endoscopy equipment market has strong growth potential and is likely to offer attractive economic conditions for a range of industry players in the coming years. The study evaluates global endoscopy equipment market to be valued at more than US$27.5 bn by the end of 2017 and further rise to US$33.5 bn by 2022. At this pace, the market is likely to exhibit a solid 4% CAGR between 2017 and 2022. The steady rise in the application of endoscopy in diverse end-use diagnostic fields, growing product development scenario in the medical devices sector, and the flourishing healthcare sector in urbanized economies are the prime factors supporting growth of the endoscopy equipment market.

This report also studies the competitive dynamics and geographical distribution of the global endoscopy equipment market in order to elucidate the major dynamics affecting the global market. It has been analyzed in the study that the endoscopy equipment market is likely to benefit from growing product development trend significantly in the coming years due to the rising number of players looking to carve out a significant share of the market, which has served to boost competition. In order to understand the geographical presence of the endoscopy equipment market, the report studies market’s performance in North America, Latin America, Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa.

Moreover, the research broadly categorizes global endoscopy equipment into leading segments of product type, application and end use. By product type, the global endoscopy equipment market is segmented into endoscopes, operative devices, visualization systems, and others. On the other hand, key end users include hospitals, diagnostic centers, specialized clinics, and others. Leading applications of endoscopy equipment include gastroenterology, pulmonology, otorhinolaryngology, gynecology, respiratory tract monitoring, urology, orthopedics and others. Of these, Gastroenterology is the leading application of endoscopy equipment and has gained increased demand.

Browse Full Report with TOC@

Later, the report covers detailed competitive view that includes market share and profiles of crucial players operating in the global market. Leading endoscopy equipment producers analyzed in the report include Arthrex Inc., Stryker Corporation, Karl Storz GmbH & Co. KG, B. Braun Melsungen AG, Boston Scientific Corporation, Olympus Corporation, Cook Medical Inc., Smith & Nephew Plc, Fujifilm Holdings Corporation, and Medtronic Plc.

Enquire About this Report@

 Antibodies are increasingly becoming the preferred choice to treat several disorders such as respiratory diseases, oncology, and autoimmune diseases. Many of these antibodies are being approved for diseases like inflammation and cancer. At present, monoclonal antibodies are widely used for the treatment of various types of cancers. A lot of research is conducting to create monoclonal antibodies that are able to cure various diseases. Rising incidence of cancer and other chronic diseases is engendering the high demand for biologics, which is serving as the key contributing factor for the growth of monoclonal antibodies industry. To provide comprehensive view of the global market, a study titled “Monoclonal Antibodies– Global Trends in the Competitive, Technological and R&D Landscape” has been broadcasted to the wide repository of Market Research Hub (MRH). This study provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of mAbs, and assesses key developments in manufacturing and development, covering strategies to combat challenges associated with the use of mAbs in human patients.

Request Free Sample Report@

Apart from the above elements, the readers will be able to understand the current status of the field of therapeutic monoclonal antibodies, and the relative clinical and commercial success of currently marketed products. It has been analyzed that a substantial number of mAb products have entered the market in the recent past. However, the majority are still in early-stage development, indicating delays and setbacks in the progression of potential products. Current facts and figures reveal that the pipeline is highly active, with 2,836 mAbs currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. Additionally, there are currently 85 mAb programs in Phase III development, and 22 at the Pre-registration stage, accounting for just under 4% of the total mAb pipeline.

Monoclonal antibodies can be defined as, a collection of antibodies produced from a single B-cell clone. These antibodies, therefore, share binding specificity towards a certain antigen and can be used as a means of targeted therapy within a number of indications across the pharmaceutical market. Also, growing awareness levels amongst patients and physicians pertaining to the applications of mAb therapy are contributing toward further growth in the market. The report further also stated that mAbs are the largest and fastest-growing segment of the biopharmaceutical sector, and account for almost half of the global revenue accrued from this area annually.

Browse Full Report with TOC@

Additionally, a granular assessment of the pipeline is provided across the four most active therapy areas for mAbs: oncology, infectious diseases, immunology and central nervous system disorders. For each of these, the study assesses the pipeline for mAbs split by therapy area, mAb type, and stage of development. Key marketed products included in the study are Remicade, Lucentis, Rituxan, Avastin, Herceptin, Opdivo, Humira, Stelara and Soliris.

Moreover, the report provides a detailed assessment of the prevailing vendor landscape. It also profiles the leading players operating in the market and leveraging industry-leading analytical tools, gauges the threats and opportunities that these companies may face over the course of the forecast period between 2016 and 2024.

Enquire About this Report@


About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: – 800-998-4852 (US-Canada)
Read Industry News at :-

Matched content

Editor’s pick